Recently, there’s been a lot going on in the world of vaccines—measles outbreaks, an abandoned attempt to create a bird flu vaccine, and a new COVID variant. All this has overshadowed some significant developments related to vaccination. So, let’s break down what’s happening.
What’s changed: Last month, Health Secretary Robert F. Kennedy Jr. stated that the CDC would stop recommending COVID booster shots for healthy children and pregnant women. This is a shift from the previous guidance that suggested everyone over six months should receive annual boosters. The CDC’s response seemed to soften this a bit, saying that these groups “may” get boosters if advised by their doctors.
What it means: The administration appears to be trying to reduce the number of people they suggest should get boosted. Some of these changes seem to align with scientific evidence, while others are less clear. Dr. Nirav Shah, a former top CDC official, mentioned that there’s some debate among experts about whether young children should be boosted—he once recommended it but noted that many other nations do not, largely due to young kids typically facing a low risk of severe illness. Additionally, COVID vaccines have also been linked to some side effects, like myocarditis, particularly in young males.
However, when it comes to pregnant women, the case for boosters seems stronger. Shah argues they are safe and effective and that vaccination helps protect infants who can’t get vaccinated themselves.
There’s also concern about how these changes were announced. Normally, health agencies consult advisers before making recommendations, but Kennedy seems to have gone ahead without that input, which surprised CDC officials. This lack of process raises questions about the reliability of the conclusions drawn.
Kennedy believes that earlier public health missteps have damaged trust, and to an extent, he has a point. Experts have at times failed to communicate clearly that scientific understanding can evolve, causing confusion when recommendations changed. There have also been instances where risk assessments were exaggerated.
Still, the inconsistencies in the current administration’s messaging are a cause for concern. Kennedy’s announcement directly contradicts prior assessments that cited pregnancy as a factor putting women at high risk for severe COVID-19.
Shah expressed worry that dwindling trust in federal health authorities could be problematic if another emergency arises.
On another note, COVID continues to evolve. The new variant, NB.1.8.1, has caused a surge in cases in places like China, but for now, Shah doesn’t seem too alarmed. This variant is a descendant of Omicron, which was prevalent in the U.S. in early 2022. So, even if cases rise, current vaccines and prior infections might still provide protection against severe illness. The WHO has indicated that this new variant doesn’t pose an increased public health risk at this time.
What’s changed: A few months back, bird flu was causing significant issues for livestock, but the outbreak has recently slowed down. The last reported human cases were in February, and only one fatality was noted.
What it means: It’s possible the bird flu is seasonal, which might explain the decline. However, another concern is that fewer cases are being tested and reported. The administration previously had difficulties regarding testing personnel.
Given that uncertainty, many experts criticize the administration for canceling contracts with Moderna for developing a bird flu vaccine. Instead, they are pursuing a project to develop a vaccine using methods similar to those for seasonal flu vaccines, which are generally slower to produce.
What’s changed: Measles cases have risen across the U.S., albeit slowly. The largest outbreak in West Texas seems to be declining now. Sadly, three unvaccinated individuals have died this year.
What it means: While a deceleration in case rates is a positive sign, official statistics might not reflect the true extent of illness. The measles vaccine is both safe and effective, yet Kennedy has been slow to recommend it strongly as outbreaks have increased.
